Dr. Jennifer Van Eyk is currently the director of the Advanced Biosystems Research Institute at Cedars-Sinai Medical Center, LA and she also holds the inaugural Erika Glazer Endowed Chair in Women’s Heart Health. Dr. Van Eyk’s lab focuses on developing technical pipelines for de novo discovery and larger scale quantitative mass spectrometry methods for the continuous assessments of cohorts focusing on health assessment. The Precision Biomarkers Laboratories, an outgrowth of her lab, is comprised of three independent commercial laboratories, aimed at facilitating the move from discovery to clinical assays for personalized biomarkers. Current, she is part of the Innovation Center, driving single cell phenotyping of patients samples for individualized therapy development.